HYSTA Entrepreneurship Development Program proudly announces its Healthcare Series event, “Innovation Trend and Career Opportunities in Life Science and Digital Health”.

Traditionally, the health care system focuses on diagnosing and treating diseases.  Innovation resources in health care were concentrated on developing billion dollar “One Size Fits All” pharmaceuticals.  Recently, advances in life sciences and information technology have created new opportunities in health care innovations.  Many innovative companies have started to develop more efficient, interdisciplinary approaches in health care and health maintenance.

In the US, consumer life style issues such as conditions related to obesity and smoking cost about $400 billion a year.  Another $177 billion in heath cost is attributed to non-adherence to drug regime. Innovations in health care related social networking applications, mobile health care apps, games and other consumer digital health products can play a significant role in reducing life style related health care costs and improving health care delivery.  With the advancement of genomics and bioinformatics, personalized medicine is closer to being a reality and will have a dramatic impact on the health care system and will also offer great opportunities for entrepreneurship and career development.

In this meeting, we will discuss health care innovations and career opportunities for life scientists, engineers, entrepreneurs, business executives and others.

===========================
1.  Health care market overview
2.  Key areas of opportunities
3.  Skill sets
4.  Challenges
============================

Speaker:

·  Wei Zhou, President and CEO, Centrillion Biosciences, Inc. 

Moderator:

·  AJ Chen, Director of Semantic Technology at Healthline, Inc.

Event Details

Date & Time:   August 23rd, 2011 

                      6:00PM – 6:30PM: Registration, Network & Mingle

                      6:30PM – 8:00PM: Talks and Roundtable Discussions

Location:        Google Main Campus Building 41

                     1600 Amphitheatre Pkwy, Mountain View, CA

Fee:               Free of charge by RSVP (limited seating), $10 at door

Registration:   RSVP at http://trendsandcareeropps.eventbrite.com

Event Host and Contact

Sue Xu, HYSTA Entrepreneurship Development Program

E-mail: sue.xu@hysta.us

Speakers Bios: 

Wei Zhou is an executive and attorney with over 20 years of broad experience in life sciences and informatics.  He founded Centrillion Biosciences in 2009 to address critical market needs in genomics and bioinformatics.  Before founding Centrillion, he was a partner at Wilson Sonsini Goodrich & Rosati (WSGR), a top ranked global technology law firm, where he counseled life sciences and clean tech companies on intellectual property, corporate law and business strategy. Prior to WSGR, he served as Vice President of Intellectual Property and Advanced Technology and China Country Manager at Affymetrix, Inc., a pioneer in DNA chip technology.  In addition, he has served on boards of directors and advisory boards of a number of life sciences and digital media companies and non-profit organizations.

He received his postdoctoral training from Emory University School of Medicine, his Ph.D. from Virginia Tech and his J.D. from Stanford University. 

AJ Chen, is an advocate of semantic web and personalized healthcare. Currently as the Director of Semantic Technology at Healthline Networks, AJ designs and develops the semantic analysis engine that powers consumer focused health search engines.  After starting SDForum Semantic Web SIG in 2007, AJ has been regularly organizing public forums in Silicon Valley to discuss how semantic technology is reshaping the web and enterprise applications. From 2000 to 2006, AJ developed new genome sequencing technologies for personalized medicine, playing various roles of software development, at Hyseq, Callida Genomics, and Complete Genomics.  In 1990s, he worked with Nobel Prize winner Dr. Barry Marshall to commercialize breakthrough medical innovations in China.  AJ earned his Ph.D. in Biochemistry from University of Utah and did postdoctoral research after joining Harvard Medical School and Duke Medical School.